Trial intelligence / Profile preview

Vitamin D Supplementation for GDM Prevention in Pakistan

NCT06139133Not yet recruiting

Sponsor
Riphah International University
Start
Jan 2024
Primary completion
Dec 2025
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Randomised trial in gestational diabetes mellitus (GDM) comparing Vitamin D3 Group with Placebo Group (2 arms). Primary endpoint: Incidence of Gestational Diabetes Mellitus. Planned start Jan 2024; status: not yet recruiting.

02

Drugs

vitamin d
03

Conditions

gestational diabetes mellitus (GDM)

Beyond the preview

Go deeper on NCT06139133.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06139133.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call